Nanoencapsulation Strategies for Active Compounds Delivery
1
Laboratory of Drug Delivery Technology, Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy
2
Department of Life & Environmental Sciences, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy
*
Authors to whom correspondence should be addressed.
Nanomaterials 2022, 12(8), 1319; https://doi.org/10.3390/nano12081319
Submission received: 7 April 2022
/
Accepted: 8 April 2022
/
Published: 12 April 2022
(This article belongs to the Special Issue Nanoencapsulation Strategies for Active Compounds Delivery)
Nanoencapsulation strategies, including the possibility to deliver natural compounds, synthetic molecules, or other actives (viruses) for the treatment of different human diseases, represent a hot topic of great interest. This Special Issue gathers results and new insights on different nanoencapsulation strategies, which specifically focus on lipid nanoparticles [1,2,3,4], polymeric nanoparticles [5,6], vesicular systems [7,8,9], and nanohydrogel [10].
The delivery of powerful natural antioxidants by solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) has been described, demonstrating the ability of lipid nanoparticles in improving the drug bioavailability of Diosgenin [1], Astaxanthin [2], N-palmitoylethanolamide [3], and Ferulic Acid, in combination with Lavender essential oil [4], thus offering promising strategies for the cutaneous, ophthalmic, and systemic treatment of diseases involving inflammation.
Some of these, such as ferulic acid, have also been investigated in vesicular systems, demonstrating the possibility to exploit multiple emulsions as an innovative and efficient vehicle for its cutaneous application [5]. Nanoemulsions represent versatile delivery systems, as demonstrated by the study regarding the ophthalmic delivery of the traditional corticosteroid Triamcinolone acetonide [6]. The preparation method of the nanoemulsion was exploited to prepared nanohydrogel for the delivery of Oncolytic viruses as potential anti-cancer treatment [7].
Among vesicular systems, liposomes have also been proposed for the delivery of the natural anti-inflammatory hydroxycitrate [8].
Polymeric nanoparticles with a special focus on nanocapsules have been reviewed [9]. In this field, an interesting approach was developed investigating the delivery of Curcumin by both lipid and polymeric nanoparticles to exploit its anti-inflammatory and antioxidant activity via intranasal administration [10].
Readers will certainly find other interesting aspects exploiting the possibility to study the implication of the different strategies presented in this Special Issue on the delivery of active compounds.
We hope that all readers will enjoy it.
Funding
This research was funded by University of Catania, Ricerca di Ateneo 2020–2022, Piano di incentivi per la ricerca (PIA.CE.RI.), Linea di intervento 2, project’s title “Naso, Nanomedicina e Neuroterapie: le 3 N per il target cerebrale di molecole bioattive (3N-ORACLE)”.
Acknowledgments
The editors acknowledge all the contributing authors for submitting their valuable research to this Special Issue.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Iordache, T.A.; Badea, N.; Mihaila, M.; Crisan, S.; Pop, A.L.; Lacatusu, I. Challenges in Coopted Hydrophilic and Lipophilic Herbal Bioactives in the Same Nanostructured Carriers for Effective Bioavailability and Anti-Inflammatory Action. Nanomaterials 2021, 11, 3035. [Google Scholar] [CrossRef]
- Santonocito, D.; Raciti, G.; Campisi, A.; Sposito, G.; Panico, A.; Siciliano, E.A.; Sarpietro, M.G.; Damiani, E.; Puglia, C. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 2021, 11, 391. [Google Scholar] [CrossRef] [PubMed]
- Puglia, C.; Santonocito, D.; Ostacolo, C.; Sommella, E.M.; Campiglia, P.; Carbone, C.; Drago, F.; Pignatello, R.; Bucolo, C. Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile. Nanomaterials 2020, 10, 287. [Google Scholar] [CrossRef] [Green Version]
- Carbone, C.; Caddeo, C.; Grimaudo, M.A.; Manno, D.E.; Serra, A.; Musumeci, T. Ferulic Acid-NLC with Lavandula Essential Oil: A Possible Strategy for Wound-Healing? Nanomaterials 2020, 10, 898. [Google Scholar] [CrossRef] [PubMed]
- Mancuso, A.; Cristiano, M.C.; Pandolfo, R.; Greco, M.; Fresta, M.; Paolino, D. Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation. Nanomaterials 2021, 11, 425. [Google Scholar] [CrossRef] [PubMed]
- Fernandes, A.R.; Sanchez-Lopez, E.; Santini, A.; dos Santos, T.; Garcia, M.L.; Silva, A.M.; Souto, E.B. Mono- and Dicationic DABCO/Quinuclidine Composed Nanomaterials for the Loading of Steroidal Drug: 32 Factorial Design and Physicochemical Characterization. Nanomaterials 2021, 11, 2758. [Google Scholar] [CrossRef] [PubMed]
- Deng, S.; Iscaro, A.; Zambito, G.; Mijiti, Y.; Minicucci, M.; Essand, M.; Lowik, C.; Muthana, M.; Censi, R.; Mezzanotte, L.; et al. Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy. Nanomaterials 2021, 11, 144. [Google Scholar] [CrossRef] [PubMed]
- Vassallo, A.; Santoro, V.; Pappalardo, I.; Santarsiero, A.; Convertini, P.; De Luca, M.; Martelli, G.; Infantino, V.; Caddeo, C. Liposome-Mediated Inhibition of Inflammation by Hydroxycitrate. Nanomaterials 2020, 10, 2080. [Google Scholar] [CrossRef] [PubMed]
- Deng, S.; Gigliobianco, M.R.; Censi, R.; Di Martino, P. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities. Nanomaterials 2020, 10, 847. [Google Scholar] [CrossRef] [PubMed]
- Bonaccorso, A.; Pellitteri, R.; Ruozi, B.; Puglia, C.; Santonocito, D.; Pignatello, R.; Musumeci, T. Curcumin Loaded Polymeric vs. Lipid Nanoparticles: Antioxidant Effect on Normal and Hypoxic Olfactory Ensheathing Cells. Nanomaterials 2021, 11, 159. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Carbone, C.; Caddeo, C.; Musumeci, T. Nanoencapsulation Strategies for Active Compounds Delivery. Nanomaterials 2022, 12, 1319. https://doi.org/10.3390/nano12081319
AMA Style
Carbone C, Caddeo C, Musumeci T. Nanoencapsulation Strategies for Active Compounds Delivery. Nanomaterials. 2022; 12(8):1319. https://doi.org/10.3390/nano12081319
Chicago/Turabian StyleCarbone, Claudia, Carla Caddeo, and Teresa Musumeci. 2022. "Nanoencapsulation Strategies for Active Compounds Delivery" Nanomaterials 12, no. 8: 1319. https://doi.org/10.3390/nano12081319
APA StyleCarbone, C., Caddeo, C., & Musumeci, T. (2022). Nanoencapsulation Strategies for Active Compounds Delivery. Nanomaterials, 12(8), 1319. https://doi.org/10.3390/nano12081319
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
